Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 759

1.

The impact of drug order complexity on prospective medication order review and verification time.

Dakwa DS, Marshall VD, Chaffee BW.

J Am Med Inform Assoc. 2019 Oct 18. pii: ocz188. doi: 10.1093/jamia/ocz188. [Epub ahead of print]

PMID:
31626294
2.

Risk factors for Kaposi's sarcoma associated herpesvirus (KSHV) DNA in blood and in saliva in rural Uganda.

Nalwoga A, Nakibuule M, Marshall V, Miley W, Labo N, Cose S, Whitby D, Newton R.

Clin Infect Dis. 2019 Sep 26. pii: ciz916. doi: 10.1093/cid/ciz916. [Epub ahead of print]

PMID:
31555829
3.

How adverse events and permanent medication stoppages affect changes in patients' beliefs about oral antineoplastic agents.

Marshall VK, Given CW, Sikorskii A, Given BA, Lehto RH.

Support Care Cancer. 2019 Sep 16. doi: 10.1007/s00520-019-05073-9. [Epub ahead of print]

PMID:
31529159
4.

Utilization of Cardiac Rehabilitation Among Cardiac Intensive Care Unit Survivors.

Sola M, Thompson AD, Coe AB, Marshall VD, Thomas MP, Prescott HC, Konerman MC.

Am J Cardiol. 2019 Aug 7. pii: S0002-9149(19)30869-0. doi: 10.1016/j.amjcard.2019.07.039. [Epub ahead of print]

PMID:
31500818
5.

Understanding Multilevel Factors Related to Urban Community Trust in Healthcare and Research.

Webb Hooper M, Mitchell C, Marshall VJ, Cheatham C, Austin K, Sanders K, Krishnamurthi S, Grafton LL.

Int J Environ Res Public Health. 2019 Sep 6;16(18). pii: E3280. doi: 10.3390/ijerph16183280.

6.

High accuracy theoretical investigations of CaF, SrF, and BaF and implications for laser-cooling.

Hao Y, Pašteka LF, Visscher L, Aggarwal P, Bethlem HL, Boeschoten A, Borschevsky A, Denis M, Esajas K, Hoekstra S, Jungmann K, Marshall VR, Meijknecht TB, Mooij MC, Timmermans RGE, Touwen A, Ubachs W, Willmann L, Yin Y, Zapara A; (NL-eEDM Collaboration).

J Chem Phys. 2019 Jul 21;151(3):034302. doi: 10.1063/1.5098540.

PMID:
31325929
7.

Evolution of interdisciplinary geriatric transitions of care on readmission rates.

Farhat NM, Vordenberg SE, Marshall VD, Suh TT, Remington TL.

Am J Manag Care. 2019 Jul 1;25(7):e219-e223.

8.

Impact of Dosing Conversion From Basal Insulin to Follow-On Insulin Glargine.

Maes ML, Ashjian EJ, Kippes KA, Marshall V, Rida N, Thompson AN.

J Pharm Pract. 2019 Jul 7:897190019853957. doi: 10.1177/0897190019853957. [Epub ahead of print]

PMID:
31280640
9.

Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.

Labo N, Marshall V, Miley W, Davis E, McCann B, Stolka KB, Ndom P, Hemingway-Foday JJ, Abassora M, Newton R, Smith JS, Whitby D.

Int J Cancer. 2019 Nov 1;145(9):2468-2477. doi: 10.1002/ijc.32546. Epub 2019 Jul 18.

PMID:
31265124
10.

Challenges of Caregivers of Cancer Patients who are on Oral Oncolytic Therapy.

Marshall VK, Cairns PL.

Semin Oncol Nurs. 2019 Aug;35(4):363-369. doi: 10.1016/j.soncn.2019.06.009. Epub 2019 Jun 19. Review.

PMID:
31229341
11.

Incidence and Risk Factors for Breakthrough Invasive Mold Infections in Acute Myeloid Leukemia Patients Receiving Remission Induction Chemotherapy.

Patel HP, Perissinotti AJ, Patel TS, Bixby DL, Marshall VD, Marini BL.

Open Forum Infect Dis. 2019 Apr 12;6(5):ofz176. doi: 10.1093/ofid/ofz176. eCollection 2019 May.

12.

Relationship between human leukocyte antigen alleles and risk of Kaposi's sarcoma in Cameroon.

Cornejo Castro EM, Morrison BJ, Marshall VA, Labo N, Miley WJ, Clements N, Nelson G, Ndom P, Stolka K, Hemingway-Foday JJ, Abassora M, Gao X, Smith JS, Carrington M, Whitby D.

Genes Immun. 2019 May 20. doi: 10.1038/s41435-019-0077-9. [Epub ahead of print]

PMID:
31105266
13.

The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa.

Blumenthal MJ, Schutz C, Barr D, Locketz M, Marshall V, Whitby D, Katz AA, Uldrick T, Meintjes G, Schäfer G.

J Infect Dis. 2019 Jul 31;220(5):841-851. doi: 10.1093/infdis/jiz180.

PMID:
31004430
14.

Knockout of von Willebrand factor in Zebrafish by CRISPR/Cas9 mutagenesis.

Iyer N, Tcheuyap VT, Schneider S, Marshall V, Jagadeeswaran P.

Br J Haematol. 2019 Aug;186(4):e76-e80. doi: 10.1111/bjh.15910. Epub 2019 Apr 9. No abstract available.

PMID:
30968393
15.

Viral, immunologic, and clinical features of primary effusion lymphoma.

Lurain K, Polizzotto MN, Aleman K, Bhutani M, Wyvill KM, Gonçalves PH, Ramaswami R, Marshall VA, Miley W, Steinberg SM, Little RF, Wilson W, Filie AC, Pittaluga S, Jaffe ES, Whitby D, Yarchoan R, Uldrick TS.

Blood. 2019 Apr 18;133(16):1753-1761. doi: 10.1182/blood-2019-01-893339. Epub 2019 Feb 19.

16.

Impact of an Antimicrobial Stewardship Intervention on Within- and Between-Patient Daptomycin Resistance Evolution in Vancomycin-Resistant Enterococcus faecium.

Kinnear CL, Patel TS, Young CL, Marshall V, Newton DW, Read AF, Woods RJ.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e01800-18. doi: 10.1128/AAC.01800-18. Print 2019 Apr.

17.

Conceptualisation of medication beliefs among patients with advanced cancer receiving oral oncolytic agents using a theory derivation approach.

Marshall VK, Lehto RH, Given CW, Given BA, Sikorskii A.

Eur J Cancer Care (Engl). 2019 Mar;28(2):e12988. doi: 10.1111/ecc.12988. Epub 2019 Jan 17.

PMID:
30656774
18.

Implementation of a text message reminder service in an independent community pharmacy: A retrospective analysis of time to prescription pickup and satisfaction.

Mitrzyk BM, Bici A, Barras M, Holm J, Marshall V, Farris KB.

J Am Pharm Assoc (2003). 2019 Mar - Apr;59(2S):S67-S70. doi: 10.1016/j.japh.2018.10.001. Epub 2018 Dec 17.

PMID:
30573374
19.

Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions.

Marshall VA, Labo N, Sztuba-Solinska J, Cornejo Castro EM, Aleman K, Wyvill KM, McNamara L, Le Grice SFJ, Yarchoan R, Uldrick TS, MacPhail P, Polizzotto MN, Whitby D.

Oncotarget. 2018 Nov 9;9(88):35856-35869. doi: 10.18632/oncotarget.26321. eCollection 2018 Nov 9.

20.

Linking the patient-centered medical home to community pharmacy via an innovative pharmacist care model.

Farris KB, Mitrzyk BM, Batra P, Peters J, Diez HL, Yoo A, McKay K, Friend K, Danko L, Waber R, Marshall VD, Choe HM.

J Am Pharm Assoc (2003). 2019 Jan - Feb;59(1):70-78.e3. doi: 10.1016/j.japh.2018.09.009. Epub 2018 Nov 8.

PMID:
30416067
21.

Impact of Oral Anticancer Medication From a Family Caregiver Perspective.

Marshall VK, Vachon EA, Given BA, Lehto RH.

Oncol Nurs Forum. 2018 Sep 1;45(5):597-606. doi: 10.1188/18.ONF.597-606.

22.

Epstein-Barr virus load is higher in long-term Hodgkin lymphoma survivors compared to their unaffected twins and unrelated controls.

Hwang AE, Marshall V, Conti DV, Nathwani BN, Mack TM, Whitby D, Cozen W.

Br J Haematol. 2019 Apr;185(2):377-380. doi: 10.1111/bjh.15522. Epub 2018 Aug 16. No abstract available.

PMID:
30117152
23.

Root condensed tannins vary over time, but are unrelated to leaf tannins.

Dettlaff MA, Marshall V, Erbilgin N, Cahill JF Jr.

AoB Plants. 2018 Jul 23;10(4):ply044. doi: 10.1093/aobpla/ply044. eCollection 2018 Aug.

24.

Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands.

Miller JT, Zhao H, Masaoka T, Varnado B, Cornejo Castro EM, Marshall VA, Kouhestani K, Lynn AY, Aron KE, Xia A, Beutler JA, Hirsch DR, Tang L, Whitby D, Murelli RP, Le Grice SFJ.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00233-18. doi: 10.1128/AAC.00233-18. Print 2018 Oct.

25.

Virtual simulation to personalize student learning in a required pharmacy course.

Ambroziak K, Ibrahim N, Marshall VD, Kelling SE.

Curr Pharm Teach Learn. 2018 Jun;10(6):750-756. doi: 10.1016/j.cptl.2018.03.017. Epub 2018 Apr 6.

PMID:
30025776
26.

Genome-Wide Sequence Analysis of Kaposi Sarcoma-Associated Herpesvirus Shows Diversification Driven by Recombination.

Sallah N, Palser AL, Watson SJ, Labo N, Asiki G, Marshall V, Newton R, Whitby D, Kellam P, Barroso I.

J Infect Dis. 2018 Oct 20;218(11):1700-1710. doi: 10.1093/infdis/jiy427.

27.

Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV.

Marshall VA, Labo N, Hao XP, Holdridge B, Thompson M, Miley W, Brands C, Coalter V, Kiser R, Anver M, Golubeva Y, Warner A, Jaffe ES, Piatak M Jr, Wong SW, Ohlen C, MacAllister R, Smedley J, Deleage C, Del Prete GQ, Lifson JD, Estes JD, Whitby D.

PLoS Pathog. 2018 Jul 12;14(7):e1007130. doi: 10.1371/journal.ppat.1007130. eCollection 2018 Jul.

28.

Factors Associated With Medication Beliefs in Patients With Cancer: An Integrative Review.

Marshall VK, Given BA.

Oncol Nurs Forum. 2018 Jul 2;45(4):508-526. doi: 10.1188/18.ONF.508-526. Review.

29.

Group medical visits after heart failure hospitalization: Study protocol for a randomized-controlled trial.

Wu WC, Parent M, Dev S, Hearns R, Taveira TH, Cohen L, Shell-Boyd J, Jewett-Tennant J, Marshall V, Gee J, Schaub K, LaForest S, Ball S.

Contemp Clin Trials. 2018 Aug;71:140-145. doi: 10.1016/j.cct.2018.06.015. Epub 2018 Jun 22.

PMID:
29940335
30.

Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.

Parikh ND, Marshall VD, Green M, Lawrence TS, Razumilava N, Owen D, Singal AG, Feng M.

J Med Imaging Radiat Oncol. 2018 Oct;62(5):673-681. doi: 10.1111/1754-9485.12754. Epub 2018 Jun 7.

PMID:
29877615
31.

Erratum to "Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda" [Cancer Epidemiol. 52 (2018) 70-74].

Ravell J, Otim I, Nabalende H, Legason ID, Reynolds SJ, Ogwang MD, Ndugwa CM, Marshall V, Whitby D, Goedert JJ, Engels EA, Bhatia K, Lenardo MJ, Mbulaiteye SM.

Cancer Epidemiol. 2018 Aug;55:192. doi: 10.1016/j.canep.2018.05.010. Epub 2018 Jun 1. No abstract available.

PMID:
29861403
32.

Determinants of Gammaherpesvirus Shedding in Saliva Among Ugandan Children and Their Mothers.

Newton R, Labo N, Wakeham K, Marshall V, Roshan R, Nalwoga A, Sebina I, Muhangi L, Webb EL, Miley W, Rochford R, Elliott AM, Whitby D.

J Infect Dis. 2018 Aug 14;218(6):892-900. doi: 10.1093/infdis/jiy262.

33.

A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia.

Foolad F, Huang AM, Nguyen CT, Colyer L, Lim M, Grieger J, Li J, Revolinski S, Mack M, Gandhi T, Wainaina JN, Eschenauer G, Patel TS, Marshall VD, Nagel J.

J Antimicrob Chemother. 2018 May 1;73(5):1402-1407. doi: 10.1093/jac/dky021.

PMID:
29462306
34.

T-cell responses to KSHV infection: a systematic approach.

Roshan R, Labo N, Trivett M, Miley W, Marshall V, Coren L, Cornejo Castro EM, Perez H, Holdridge B, Davis E, Matus-Nicodemos R, Ayala VI, Sowder R 2nd, Wyvill KM, Aleman K, Fennessey C, Lifson J, Polizzotto MN, Douek D, Keele B, Uldrick TS, Yarchoan R, Ohlen C, Ott D, Whitby D.

Oncotarget. 2017 Nov 25;8(65):109402-109416. doi: 10.18632/oncotarget.22683. eCollection 2017 Dec 12.

35.

No treatment-related effects with aryloxyalkanoate dioxygenase-12 in three 28-day mouse toxicity studies.

Papineni S, Thomas J, Marshall VA, Juberg DR, Herman RA.

Regul Toxicol Pharmacol. 2018 Feb;92:220-225. doi: 10.1016/j.yrtph.2017.12.012. Epub 2017 Dec 16.

36.

Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda.

Ravell J, Otim I, Nabalende H, Legason ID, Reynolds SJ, Ogwang MD, Ndugwa CM, Marshall V, Whitby D, Goedert JJ, Engels EA, Bhatia K, Lenardo MJ, Mbulaiteye SM.

Cancer Epidemiol. 2018 Feb;52:70-74. doi: 10.1016/j.canep.2017.12.004. Epub 2017 Dec 14. Erratum in: Cancer Epidemiol. 2018 Aug;55:192.

37.

Residents as preceptors and educators: What we can learn from a national survey to improve our residency programs.

DiPaula BA, Mohammad RA, Ayers P, Basalyga V, Burton A, Bush C, Farthing K, Marshall VD, Shah BM.

Curr Pharm Teach Learn. 2018 Jan - Feb;10(1):21-27. doi: 10.1016/j.cptl.2017.09.006. Epub 2017 Oct 6.

PMID:
29248070
38.

Do treatment patterns alter beliefs cancer patients hold regarding oral oncolytic agents?

Sikorskii A, Given CW, Given BA, Vachon E, Marshall V, Krauss JC, Banik A, Majumder A.

Psychooncology. 2018 Mar;27(3):1005-1012. doi: 10.1002/pon.4606. Epub 2018 Jan 11.

39.

Tracheostomy as a Comfort Measure in Children With Life-Limiting Conditions.

Marshall V, Holt F, Crowe S.

J Palliat Care. 2017 Jul/Oct;32(3-4):89-91. doi: 10.1177/0825859717740064. Epub 2017 Nov 7.

PMID:
29110572
40.

Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort.

Coughtrie AL, Behr ER, Layton D, Marshall V, Camm AJ, Shakir SAW.

BMJ Open. 2017 Oct 16;7(10):e016627. doi: 10.1136/bmjopen-2017-016627.

41.

Using Qualitative Methods to Understand Perceptions of Risk and Condom Use in African American College Women: Implications for Sexual Health Promotion.

McLaurin-Jones TL, Lashley MB, Marshall VJ.

Health Educ Behav. 2017 Oct;44(5):805-814. doi: 10.1177/1090198117728759. Epub 2017 Sep 7.

PMID:
28882079
42.

Reply.

Parikh ND, Singal AG, Lok AS, Balkrishnan R, Shahinian V, Marshall VD.

Hepatology. 2017 Aug;66(2):679-680. doi: 10.1002/hep.29248. Epub 2017 Jun 28. No abstract available.

43.

Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.

Sanchez-Martin D, Uldrick TS, Kwak H, Ohnuki H, Polizzotto MN, Annunziata CM, Raffeld M, Wyvill KM, Aleman K, Wang V, Marshall VA, Whitby D, Yarchoan R, Tosato G.

J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx016.

44.

A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.

Uldrick TS, Gonçalves PH, Wyvill KM, Peer CJ, Bernstein W, Aleman K, Polizzotto MN, Venzon D, Steinberg SM, Marshall V, Whitby D, Little RF, Wright JJ, Rudek MA, Figg WD, Yarchoan R.

Oncologist. 2017 May;22(5):505-e49. doi: 10.1634/theoncologist.2016-0486. Epub 2017 Mar 24.

45.

Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.

Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Peer CJ, Bevans M, Sereti I, Maldarelli F, Whitby D, Marshall V, Goncalves PH, Khetani V, Figg WD, Steinberg SM, Zeldis JB, Yarchoan R.

J Clin Oncol. 2016 Dec;34(34):4125-4131. Epub 2016 Oct 31. Erratum in: J Clin Oncol. 2018 Jul 1;36(19):2008.

46.

Clinical variation: why it matters.

Duggan A, Koff E, Marshall V.

Med J Aust. 2016 Nov 21;205(10):S3-S4. No abstract available.

PMID:
27852193
47.

The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay.

Johnson JM, Wu CY, Winder GS, Casher MI, Marshall VD, Bostwick JR.

J Dual Diagn. 2016 Jul-Dec;12(3-4):244-251. Epub 2016 Oct 6.

PMID:
27710762
48.

Dietary Route of Exposure for Rabbit Developmental Toxicity Studies.

Hannas BR, Ellis-Hutchings RG, Marshall VA, Terry C, McCoy AA, Saghir SA, Brooks K, Eisenbrandt D, Carney EW, Billington R, Rasoulpour RJ.

Toxicol Sci. 2016 Nov;154(1):90-100. Epub 2016 Aug 4.

PMID:
27492223
49.

Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.

Parikh ND, Marshall VD, Singal AG, Nathan H, Lok AS, Balkrishnan R, Shahinian V.

Hepatology. 2017 Jan;65(1):122-133. doi: 10.1002/hep.28881. Epub 2016 Nov 25.

50.

A Randomized Crossover Comparison of Team-based Learning and Lecture Format on Learning Outcomes.

Bleske BE, Remington TL, Wells TD, Klein KC, Guthrie SK, Tingen JM, Marshall VD, Dorsch MP.

Am J Pharm Educ. 2016 Sep 25;80(7):120.

Supplemental Content

Loading ...
Support Center